- Home
- TPVG vs NPCE Comparison
TPVG vs NPCE Comparison
Compare TPVG & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPVG
- NPCE
- Stock Information
- Founded
- TPVG 2013
- NPCE 1997
- Country
- TPVG United States
- NPCE United States
- Employees
- TPVG N/A
- NPCE N/A
- Industry
- TPVG Other Consumer Services
- NPCE Medical Specialities
- Sector
- TPVG Consumer Discretionary
- NPCE Health Care
- Exchange
- TPVG Nasdaq
- NPCE Nasdaq
- Market Cap
- TPVG 273.2M
- NPCE 292.9M
- IPO Year
- TPVG N/A
- NPCE 2021
- Fundamental
- Price
- TPVG $6.42
- NPCE $9.82
- Analyst Decision
- TPVG Hold
- NPCE Strong Buy
- Analyst Count
- TPVG 5
- NPCE 6
- Target Price
- TPVG $6.75
- NPCE $16.67
- AVG Volume (30 Days)
- TPVG 365.1K
- NPCE 190.1K
- Earning Date
- TPVG 11-05-2025
- NPCE 11-11-2025
- Dividend Yield
- TPVG 14.31%
- NPCE N/A
- EPS Growth
- TPVG N/A
- NPCE N/A
- EPS
- TPVG 1.03
- NPCE N/A
- Revenue
- TPVG $97,395,000.00
- NPCE $88,570,000.00
- Revenue This Year
- TPVG N/A
- NPCE $22.13
- Revenue Next Year
- TPVG $6.13
- NPCE $6.07
- P/E Ratio
- TPVG $6.24
- NPCE N/A
- Revenue Growth
- TPVG N/A
- NPCE 23.32
- 52 Week Low
- TPVG $5.53
- NPCE $5.45
- 52 Week High
- TPVG $8.50
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- TPVG 39.69
- NPCE 58.26
- Support Level
- TPVG $6.65
- NPCE $9.60
- Resistance Level
- TPVG $6.88
- NPCE $10.12
- Average True Range (ATR)
- TPVG 0.15
- NPCE 0.40
- MACD
- TPVG -0.00
- NPCE 0.10
- Stochastic Oscillator
- TPVG 20.69
- NPCE 74.46
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.